Treatment News : A Sustiva Trip? The HIV Med and LSD are Fellow Hallucinogens

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 11, 2013

A Sustiva Trip? The HIV Med and LSD are Fellow Hallucinogens

Known for its neuropsychiatric side effects, Sustiva (efavirenz) shares properties with LSD, according to a new research study. Potential side effects of Sustiva include depression, anxiety, sleep disturbances, difficulty concentrating, aggression, night terrors, hallucinations, paranoia, psychosis and delusions. In addition, anecdotal reports have suggested that people with HIV, as well as HIV-negative young people, crush the drug and smoke the powder in order to get high. In order to better understand the cause of the drug’s hallucinogenic effects, investigators conducted a study of how Sustiva interacts with various receptors in rat, rabbit and human cells; they also looked at the behavioral effects of the drugs when given to living rats and mice. Their findings were reported in Neuropsychopharmacology.

They found that Sustiva interacted with multiple receptors that are known sites governing the effects of drugs, including catecholamine and indoleamine transporters, and GABAA and 5-HT2A receptors. In particular, the serotonin 5-HT2A receptor, which is a main target for LSD and other related hallucinogens, appeared to be the dominant conduit for Sustiva’s drug-trip effects in rats.

To read a release on the study, click here.

To read the study abstract, click here.

Search: LSD, Sustiva, efavirenz, neuropsychiatric side effects, Neuropsychopharmacalogy, hallucinogenic.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    charliehunter
    San Francisco
    California


    juliar33
    brooklyn
    New York


    Deelight4u
    BROOKLYN
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.